News

Investors might want to bet on Inspire Medical Systems (INSP), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which ...
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $215.54, a high ...
Inspire Medical Systems, Inc. ( NYSE: INSP) Q1 2025 Results Conference Call May 5, 2025 5:00 PM ET Ezgi Yagci - Vice President of Investor Relations Tim Herbert - President & Chief Executive Officer ...
Medical technology company Inspire Medical Systems (NYSE:INSP) announced in Q1 CY2025, with sales up 22.7% year on year to ...